Here, we unravel that chemotherapy-induced acetylation of ACLY by NAT10 drives the chemoresistance in HCC through controlling nuclear acetyl-CoA production to activate the transcription of CYP2C9 and PIK3R1 genes (Fig. 8J). Here, CYP2C9 is linked to hepatocellular carcinoma.